Alem­bic pharma ac­quires US based Orit Lab

Chemical Industry Digest - - News & Views -


based Alem­bic Phar­ma­ceu­ti­cals has ac­quired US-based generic drug de­vel­oper Orit Lab­o­ra­to­ries LLC through its 100 per­cent sub­sidiary Alem­bic Phar­ma­ceu­ti­cals Inc.

Based out of New Jersey, Orit Lab­o­ra­to­ries has seven ap­proved and four pend­ing ANDAs, with an 8,600 sq ft wide R&D and pi­lot man­u­fac­tur­ing fa­cil­ity. Orit Lab­o­ra­to­ries is fo­cused on de­vel­op­ing and fil­ing oral solid and liq­uid prod­ucts, as per Alem­bic’s fil­ing on BSE on Wed­nes­day. Apart from ex­ist­ing ANDAs, Orit also brings in soft gelatin-based oral solids and oral liq­uids to Alem­bic through a team of eight ‘highly ex­pe­ri­enced’ sci­en­tists.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.